Do First-In-Class Drugs Offer Larger Incremental Health Gains Than Next-In-Class Drugs?
Abstract
Authors
J Chambers T Thorat C Wilkinson PJ Neumann
J Chambers T Thorat C Wilkinson PJ Neumann
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now